Radiological endpoints as surrogates for survival benefit in Hepatocellular Carcinoma trials: all that glitters is not gold. Cabibbo G, Bruix J. J Hepatol 2022 Oct 30. pii: S0168-8278(22)03155.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cabibbo G, Bruix J. Radiological endpoints as surrogates for survival benefit in Hepatocellular Carcinoma trials: all that glitters is not gold. J Hepatol 2022 Oct 30. pii: S0168-8278(22)03155.
PMID: 36323356